Dabur India Ltd - Stock Valuation and Financial Performance

BSE: 500096 | NSE: DABUR | Household & Personal Products | Large Cap

Dabur India Share Price

521.20 -2.60 -0.50%
as on 19-Mar'24 15:00

DeciZen - make an informed investing decision on Dabur India

Overall Rating
Bole Toh

1. Quality

2. Valuation

Fair

3. Price Trend

Semi Strong

Dabur India stock performance -

mw4me loader
P/E Ratio (CD):
51.74
Market Cap:
92,819.4 Cr.
52-wk low:
504
52-wk high:
596.9

Is Dabur India Ltd an attractive stock to invest in?

1. Is Dabur India Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Dabur India Ltd is a good quality company.

2. Is Dabur India Ltd undervalued or overvalued?

The key valuation ratios of Dabur India Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Dabur India Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Dabur India Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Dabur India:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Dabur India Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 26.9%27.2%27.1%24.3%22.3%22.8%21.9%22.5%20.3%17.7%-
Value Creation
Index
1.41.41.41.21.01.00.91.00.80.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 7,0757,8277,7807,6147,7228,5158,6859,56210,88911,53012,267
Sales YoY Gr.-10.6%-0.6%-2.1%1.4%10.3%2%10.1%13.9%5.9%-
Adj EPS 5.2677.37.78.28.29.69.89.610.1
YoY Gr.-16%16.6%3.6%6.3%5.7%0.3%17.1%2.5%-2.8%-
BVPS (₹) 14.818.823.22731.931.536.942.746.650.356.4
Adj Net
Profit
9031,0551,2321,2791,3591,4411,4451,6931,7371,6911,793
Cash Flow from Ops. 1,0981,0471,1871,2271,0921,4991,6142,1151,8021,488-
Debt/CF from Ops. 0.90.90.70.80.90.50.30.20.50.7-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 5.6%8.4%9.9%5.9%
Adj EPS 7%4.4%5.3%-2.8%
BVPS14.6%9.6%10.9%8%
Share Price 11.3% 4.1% -0.2% -2.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
37.935.132.828.425.825.423.623.721.719.519
Op. Profit
Mgn %
16.416.919.519.82120.420.720.920.718.819.1
Net Profit
Mgn %
12.813.515.916.817.71716.717.71614.614.6
Debt to
Equity
0.40.30.20.20.20.10.10.10.10.1-
Working Cap
Days
123124140128102102114108908975
Cash Conv.
Cycle
2419179-403-4-12-617

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 19.00%

Sales growth has been subdued in last 3 years 9.91%

Net Profit has been subdued in last 3 years 5.30%

Sales growth is not so good in last 4 quarters at 7.88%

Latest Financials - Dabur India Ltd.

Standalone Consolidated
TTM EPS (₹) 8.2 10.1
TTM Sales (₹ Cr.) 9,036 12,267
BVPS (₹.) 40 56.4
Reserves (₹ Cr.) 6,904 9,817
P/BV 13.11 9.29
PE 63.61 51.74
From the Market
52 Week Low / High (₹) 504.00 / 596.90
All Time Low / High (₹) 3.00 / 658.75
Market Cap (₹ Cr.) 92,819
Equity (₹ Cr.) 177.2
Face Value (₹) 1
Industry PE 56.5

Management X-Ray of Dabur India:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Dabur India

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales7,0757,8277,7807,6147,7228,5158,6859,56210,88911,530
Operating Expenses 5,9156,5116,2616,1066,1076,7786,8957,5628,6389,370
Manufacturing Costs1,2031,3001,2641,3781,3411,4661,5291,4901,8221,970
Material Costs2,3692,6082,6692,6342,7083,0793,0723,5554,1274,670
Employee Cost 5886697707627789229301,0151,0601,114
Other Costs 1,7541,9331,5581,3341,2801,3121,3641,5021,6301,616
Operating Profit 1,1601,3161,5181,5071,6151,7371,7891,9992,2502,160
Operating Profit Margin (%) 16.4%16.8%19.5%19.8%20.9%20.4%20.6%20.9%20.7%18.7%
Other Income 128158217303305296305325393445
Interest 54404859536050313978
Depreciation 97115133141160174217237250307
Exceptional Items -1000-15-75-1000-850
Profit Before Tax 1,1361,3191,5541,6111,6931,7251,7282,0562,2692,219
Tax 219251300330335279280361526517
Profit After Tax 9161,0681,2541,2801,3581,4461,4481,6951,7421,701
PAT Margin (%) 13.0%13.7%16.1%16.8%17.6%17.0%16.7%17.7%16.0%14.8%
Adjusted EPS (₹)5.26.17.17.37.78.28.29.69.89.6
Dividend Payout Ratio (%)33%33%32%31%98%34%37%50%53%54%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 2,5753,3024,0804,7585,6145,5576,5127,5408,2338,914
Share Capital 174176176176176177177177177177
Reserves 2,4013,1273,9044,5825,4385,3806,3367,3638,0568,737
Minority Interest81822252731363741468
Debt708734792911829524467350868999
Long Term Debt260211342470364261631250299
Short Term Debt448523450440464498304349617700
Trade Payables1,0971,0961,3301,3101,4101,4551,4821,9152,0182,187
Others Liabilities 1,5521,6941,5997288228698349871,1251,084
Total Liabilities 5,9396,8447,8237,7328,7028,4379,33210,82912,28413,652

Fixed Assets

Gross Block2,4132,5412,4842,7792,9823,0763,5663,7163,9795,523
Accumulated Depreciation6466648168761,0081,1591,3651,5231,7201,991
Net Fixed Assets1,7671,8771,6671,9031,9741,9172,2012,1922,2593,532
CWIP 225045424264147147168175
Investments 1,0761,8132,6303,2403,8053,3592,8004,1606,2206,265
Inventories9739731,0971,1071,2561,3011,3801,7341,9112,024
Trade Receivables675711809650706834814562646849
Cash Equivalents 5192762203053063288111,329570326
Others Assets9071,1431,3554856136351,179705510481
Total Assets 5,9396,8447,8237,7328,7028,4379,33210,82912,28413,652

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 1,0981,0471,1871,2271,0921,4991,6142,1151,8021,488
PBT 1,1361,3191,5541,6111,6931,7251,7282,0562,2692,219
Adjustment 6674-11-149-15143253-818-76
Changes in Working Capital 82-117-7587-262-18-58388-97-160
Tax Paid -186-230-281-322-325-351-309-321-388-494
Cash Flow From Investing Activity -107-876-730-807-540337-517-1,406-1,275-587
Capex -213-251-189-486-200-225-400-306-369-486
Net Investments 10-721-688-511-583317-365-1,361-1,273-14
Others 9596147190244244248262367-87
Cash Flow From Financing Activity -804-417-374-339-577-1,888-1,043-613-490-1,035
Net Proceeds from Shares 0461715000000
Net Proceeds from Borrowing -2800131129-62-272-175-28249-1
Interest Paid -34-26-40-45-43-52-42-31-33-89
Dividend Paid -279-395-352-396-396-1,325-512-592-972-921
Others -211-42-131-41-76-240-31337266-25
Net Cash Flow 187-2468281-26-52549536-133
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)39.8536.3633.9728.9726.1825.8923.9924.1222.0919.84
ROCE (%)34.1534.2934.4930.9228.0127.5126.4127.5626.7323.9
Asset Turnover Ratio1.281.241.070.991.031.091.091.051.051
PAT to CFO Conversion(x)1.20.980.950.960.81.041.111.251.030.87
Working Capital Days
Receivable Days30323535293031241821
Inventory Days46454852515051545555
Payable Days124136147173183170175174174164

Dabur India Ltd Stock News

Dabur India Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Dabur India on 19-Mar-2024 15:00 is ₹521.2.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 19-Mar-2024 15:00 the market cap of Dabur India stood at ₹92,819.4.
The latest P/E ratio of Dabur India as of 19-Mar-2024 15:00 is 63.61.
The latest P/B ratio of Dabur India as of 19-Mar-2024 15:00 is 13.11.
The 52-week high of Dabur India is ₹596.9 and the 52-week low is ₹504.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Dabur India is ₹9,036 ( Cr.) .

About Dabur India Ltd

Dabur India Limited is a leading Indian consumer goods company with interests in Hair Care, Oral Care, Health Care, Skin Care, Home Care and Foods. Dabur's FMCG portfolio today includes five flagship brands with distinct brand identities - Dabur as the master brand for natural healthcare products, Vatika for premium personal care, Hajmola for digestives, Real for fruit juices and beverages and Fem for fairness bleaches and skin care products.

Business area of the company

The company is one of the leading fast moving consumer goods (FMCG) players dealing in consumer care and food products. It has manufacturing facilities across the length and breadth of the country and research and development center in Sahibabad, U.P and selling arrangements primarily in India through independent distributors. However, most of the institutional sales are handled directly by the Company.

Products

Health Supplements

  • Dabur Chyawanprash
  • Dabur Honey
  • Dabur Glucose
  • Dabur Immunity Kit

Digestives

  • Dabur Hajmola
  • Pudin Hara
  • Dabur Nature Care Regular

Oral Care

  • Dabur Red Paste
  • Dabur Meswak
  • Dabur Babool
  • Dabur Lal Dant Manjan
  • Dabur Dant Rakshak Ayurvedic Paste

Hair Oils

  • Amla
  • Vatika
  • Almond
  • Dabur Anmol Gold Coconut Oil

Skin Care

  • Dabur Gulabari
  • Oxy Bleach
  • FEM Fairness Naturals Gold Bleach

OTC & Ethicals

  • Energisers
  • Cough & Cold
  • Dabur Ashokarishta
  • Dabur Lal Tail
  • Dabur Lauhasava
  • Dabur Amla Juice

Shampoos

  • Almond Shampoo
  • Vatika Health Shampoo
  • Vatika Black Shine Shampoo
  • Vatika Anti-Dandruff Shampoo

Foods

  • Real
  • Real Activ 100% Juices
  • Hommade

Home Care

  • Odomos
  • Odonil
  • Sanifresh
  • Odopic

Guar Gum Products

Awards

  • Dabur moves up 11 points, ranked 41 in Brand Finance India 100 list of Most valuable Companies
  • Dabur bags 6 IndiaStar awards for Excellence in Packaging
  • Dabur Ranked 44 In BT500 List of India's Most Valuable Companies
  • Dabur promoter Burman Family ranked 16th in the latest Forbes India list of 100 Richest Indians
  • Dabur ranked 25 in the list of Best Companies for CSR in India, according to the Economic Times
  • Dabur's promoters, Burman family, ranked amongst Asia's Top 50 Business Clans, by Forbes Asia
  • Dabur moves up 40 places to take 115th position in The BW Real 500 List of India's Largest Companies
  • Dabur Chyawanprash Immune India School Challenge 2014 bags Black Dragon Order of Excellence at PMAA
  • Dabur bags Best CSR Campaign of the Year Award for Sanifresh 700 se 7 Kadam
  • Dabur named Outstanding Indian Company in US, by Indo-American Chamber of Commerce
  • Dabur Among Delhi-NCR Top 50 Hot Brands
  • Two manufacturing units of Dabur bag Gold Greentech Safety Award 2015 for outstanding achievements
  • Dabur India Ltd Chief Executive Officer Mr. Sunil Duggal named Best CEO in FMCG Category for 2015
  • Dabur bags AsiaStar 2015 award for excellence in packaging for PudinHara Pearls blister pack
  • Dabur moves up 4 Places in Fortune India 500 List; ranked 163 in the list for 2015
  • Dabur ranked 48 in BI Super 100 List for 2015
  • Dabur Bags Greentech CSR Gold Award 2015 for its sanitation initiatives
  • Dabur ranked 29 in the 2015 Best Indian Brands report, released by Interbrand India
  • Dabur Hair Oil and Toothpaste in Top 100 Most Trusted Brands 2015 List, by Brand Equity
  • Dabur awarded Good Corporate Citizen of the Year award by PHDCCI
  • Dabur in Forbes’ list of India's Super 50 Companies
  • Dabur Red Paste Dant Snan and Dabur Goonj bag bronze awards at WOW Asia Awards 2016
  • Dabur named the Best Healthcare Brand in the Consumer Healthcare category by The Economic Times
  • Dabur Gastrina's advertising campaign bagged four 'Pencils' at the One Show awards
  • Dabur ranked Most Trusted Healthcare Brand in India
  • Dabur bags two awards for market research for a research
  • Dabur Ranked 33 in List Of Top Wealth Creators, by Dalal Street
  • Dabur bags Outstanding Partnership Award-Asia
  • Uttar Pradesh Government honours Dabur for its Community Health Care and Public Health initiatives
  • Dabur ranked 115 in BS 1000 List
  • Dabur India Ltd ranked 26 in the list of Best Indian Brand for 2016
  • Dabur ranked Best Healthcare Brand in Alternative Medicines category, by WCRC magazine
  • Dabur bags the prestigious BrandZ Award; Ranked amongst the Top 50 Most Valuable Indian Brands 2016
  • Dabur moves up six places; ranked 39 in BT500 ranking of India's Most Valuable Companies for 2016
  • Dabur bags AsiaStar 2016 Packaging Award for Dabur Ratnaprash
  • Odomos campaign bags Silver Effies Award
  • Dabur Toothpaste, Hajmola biggest gainers in Brand Equity Most Trusted Brands 2016 List
  • Dabur ranked as a top brand in the Best Indian Brands 2016 league table, by Interbrand India
  • Dabur India Ltd honoured with Zee Media Family Business Legacy Award
  • Dabur India Ltd bags the award for Best Risk Management Practice in the FMCG category, by CNBC TV18
  • Dabur ranked among the Iconic Brands of India 2017, by The Economic Times

Milestones

  • 1884: Birth of Dabur
  • 1896: Setting up a manufacturing plant
  • Early 1900s: Dabur enters the specialised area of nature-based Ayurvedic medicines , for which standardised drugs are not available in the market.
  • 1919: Establishment of research laboratories
  • 1920: Dabur expands further with new manufacturing units at Narendrapur and Daburgram. The distribution of Dabur products spreads to Bihar and the North-East.
  • 1936: Dabur becomes a full-fledged company - Dabur India (Dr. S. K. Burman) Private Limited
  • 1972: Dabur's operations shift to Delhi. A new manufacturing plant is set up in temporary premises in Faridabad on the outskirts of Delhi.
  • 1979: Commercial production starts in the new Sahibabad factory of Dabur, one of the largest and best equipped production facilities for Ayurvedic medicines. Launch of full-fledged research operations in pioneering areas of health care with establishment of the Dabur Research & Development Centre (DRDC).
  • 1986: Dabur becomes a Public Limited Company. Dabur India Ltd. comes into being after reverse merger with Vidogum Limited.
  • 1992: Beginning a new chapter of strategic partnerships with international businesses, Dabur enters into a joint venture with Agrolimen of Spain. This new venture is to manufacture and market confectionery items in India.
  • 1993: Dabur enters the specialised health care area of cancer treatment with its oncology formulation plant at Baddi in Himachal Pradesh.
  • 1994: Dabur India Ltd. raises its first public issue. Due to market confidence in the Company, shares issued at a high premium are oversubscribed 21 times.
  • 1995: Extending its global partnerships, Dabur enters into a Joint Venture (JV) with Osem of Israel for food and Bongrain of France for Cheese & other dairy products.
  • 1996: For better operation and management, 3 separate divisions are created according to their product mix - Health Care, Products Division, Family Product Division & Dabur Ayurvedic Specialities Limited.
  • 1997: Dabur enters full-scale in the nascent processed foods market with creation of a Foods Division. Project STARS (Strive to Achieve Record Successes) is initiated to give a jump-start to the Company and accelerate its growth performance.
  • 1998: With changing demands of business and to inculcate a spirit of corporate governance, the Burman family inducts professional to manage the company. For the first time in the history of Dabur, a non family professional CEO sits at the helm of the company.
  • 2000: Dabur establishes its market leadership status with a turnover of Rs.1,000 crore. From a small beginning and upholding the values of its founder, Dabur now enters the august league of large corporate businesses.
  • 2003: Dabur India approved the demerger of its pharmaceuticals business from the FMCG business into a separate company as part of plans to provide greater focus to both the businesses.
  • 2005: Dabur acquires Balsara 
  • 2005: Dabur announces Bonus after 12 years
  • 2006: Dabur India crosses the $2 billion mark in market Capitalisation. The company also adopted US GAAP in the line with the commitment to follow Global Best Practices and adopt highest standards of transparency and governance.
  • 2006: Moving forward on the inorganic growth path Dabur India decides to raise upto $200 million from the international market through bonds, FCCBs, GDR, ADR, QIPs or any other securities.
  • 2007: Dabur India decides to merge its wholly owned subsidiary Dabur Foods Limited with itself to exact synergies and unlock operational efficiencies.
  • 2008: Dabur India acquires Fem Care Pharma, a leading player in the women skin care market. Besides an entry into the high growth skin care market with an established brand named Fem, this transaction also offers Dabur a strong platform to enter newer product categories and markets.
  • 2009: Dabur Red Paste becomes Dabur's 9th billion rupee brand by crossing the billion rupee turnover mark within 5 years of its launch.
  • 2010: Dabur makes its first overseas acquisition
  • 2011: Dabur enters professional skin care market
  • 2011: Dabur India acquires 30-Plus from Ajanta Pharma
  • 2012: Dabur crosses Billion-Dollar Turnover Mark
  • 2013: Market Capitalisation crosses the $5-Billion mark.
  • 2015: Brand Real, Vatika and Amla cross the Rs. 1,000-crore turnover mark.
  • 2016: Dabur Gulabari and Dabur Lal Dant Manjan clock a turnover of Rs. 100 crore each.
  • 2017: Dabur launches ready-to-drink Mocktails under Real
  • 2018: Dabur Names Kriti Sanon as the New Brand Ambassador for FEM
  • 2019: Dabur expands Ayurvedic Medicines portfolio with launch of 2 new products
  • 2020: Dabur launches ‘Tulsi Drops’, a Natural Immunity Booster
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.